Advocacy intelligence hub — real-time data for patient organizations
Nutropin Depot: FDA approved
Long-term treatment of growth failure due to a lack of adequate endogenous growth hormone secetion for once- or twice-a-month administration.
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Copay cards
Copay Assistance1
Nutropin Depot
Genentech, Inc.
Nutropin Depot
(Somatropin (rDNA origin))Orphan drugGenentech, Inc.
Browse all Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins news →